| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710
We have previously reported the presence of a high molecular weight polypeptide growth factor in the plasma of normal human or rat serum which stimulates DNA synthesis in primary cultures of normal rat hepatocytes. We referred to this activity as hepatopoietin A (HPTA) (Michalopoulos, G., Houck, K. A., Dolan, M. L., and Luetteke, N. C. Control of hepatocytes replication by two serum factors. Cancer Res., 44: 44144419, 1984; Thaler, J., and Michalopoulos, G. Hepatopoietin A. Partial characterization and trypsin activation of a hepatocyte growth factor. Cancer Res., 45: 25452549, 1985). At that time, however, complete purification of this growth factor had not been achieved.
In the present report we describe the steps required for complete purification of HPTA from human plasma or rabbit serum. The purification involved sequential ammonium sulfate precipitation, heparin-affinity chromatography, anion-exchange high-performance liquid chromatography (HPLC), and reversed phase HPLC. The final purified product is a heterodimer consisting of a heavy and a light polypeptide chain with molecular weights of 70,000 and 35,000, respectively, as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. Under nonreducing conditions, however, the purified HPTA migrated as a single band on sodium dodecyl sulfate-polyacrylamide gel electrophoresis corresponding to a molecular weight of 69,000. The mitogenic activity of HPTA was associated with this band when it was eluted from unstained sodium dodecyl sulfate-polyacrylamide gels. Gel filtration HPLC under neutral isotonic conditions indicated that HPTA tends to form aggregates with molecular weights of greater than 300,000.
Chromatofocusing indicated that HPTA is an acidic protein with an isoelectric point value of about 5.5. The mitogenic activity of HPTA was sensitive to heat, trypsin, and 2-mercaptoethanol, but relatively resistant to exposure to 1 N acetic acid, 2 M guanidine-HCl, and 0.1% sodium dodecyl sulfate. The stimulation of DNA synthesis induced by HPTA was totally abrogated by transforming growth factor-ß and markedly reduced in the presence of heparin. We present biochemical as well as biological evidence that HPTA is a hepatocyte growth factor distinct from other known polypeptide mitogens such as epidermal growth factor, transforming growth factor-
, platelet-derived growth factor, fibroblast growth factor, and thrombin.
1 This work was supported in part by NIH Grants CA43632, CA35373, and CA30241, EPA Grant CR 814344, and a generous gift from Genetic Therapy Inc., Gaithersburg, MD.
2 To whom requests for reprints should be addressed, at Department of Pathology, P.O. Box 3432, Duke University Medical Center, Durham, NC27710.
Received 11/ 3/88. Revised 2/24/89. Accepted 3/21/89.
This article has been cited by other articles:
![]() |
J. Cai, J. Chen, Y. Liu, T. Miura, Y. Luo, J. F. Loring, W. J. Freed, M. S. Rao, and X. Zeng Assessing Self-Renewal and Differentiation in Human Embryonic Stem Cell Lines Stem Cells, March 1, 2006; 24(3): 516 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. McKinnon, E. Gherardi, M. Reidy, and D. Bowyer Hepatocyte Growth Factor/Scatter Factor and MET Are Involved in Arterial Repair and Atherogenesis Am. J. Pathol., January 1, 2006; 168(1): 340 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jinnin, H. Ihn, Y. Mimura, Y. Asano, K. Yamane, and K. Tamaki Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1 Nucleic Acids Res., June 21, 2005; 33(11): 3540 - 3549. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-i. Tsukada, T. Tanaka, K. Miyazawa, and N. Kitamura Involvement of Down-Regulation of Cdk2 Activity in Hepatocyte Growth Factor-Induced Cell Cycle Arrest at G1 in the Human Hepatocellular Carcinoma Cell Line HepG2 J. Biochem., November 1, 2004; 136(5): 701 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Borowiak, A. N. Garratt, T. Wustefeld, M. Strehle, C. Trautwein, and C. Birchmeier Met provides essential signals for liver regeneration PNAS, July 20, 2004; 101(29): 10608 - 10613. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Pollack, G. Apodaca, and K. E. Mostov Hepatocyte growth factor induces MDCK cell morphogenesis without causing loss of tight junction functional integrity Am J Physiol Cell Physiol, March 1, 2004; 286(3): C482 - C494. [Abstract] [Full Text] |
||||
![]() |
K. Takeuchi and F. Ito Suppression of Adriamycin-induced Apoptosis by Sustained Activation of the Phosphatidylinositol-3'-OH kinase-Akt Pathway J. Biol. Chem., January 9, 2004; 279(2): 892 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gherardi, M. E. Youles, R. N. Miguel, T. L. Blundell, L. Iamele, J. Gough, A. Bandyopadhyay, G. Hartmann, and P. J. G. Butler Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor PNAS, October 14, 2003; 100(21): 12039 - 12044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hata, E. Ikeda, H. Uno, and S. Asano Expression of Hepatocyte Growth Factor mRNA in Rat Liver Cirrhosis Induced by N-nitrosodimethylamine as Evidenced by In Situ RT-PCR J. Histochem. Cytochem., November 1, 2002; 50(11): 1461 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grenier, S. Chollet-Martin, B. Crestani, C. Delarche, J. El Benna, A. Boutten, V. Andrieu, G. Durand, M.-A. Gougerot-Pocidalo, M. Aubier, et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils Blood, April 15, 2002; 99(8): 2997 - 3004. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pediaditakis, S. P. S. Monga, W. M. Mars, and G. K. Michalopoulos Differential Mitogenic Effects of Single Chain Hepatocyte Growth Factor (HGF)/Scatter Factor and HGF/NK1 following Cleavage by Factor Xa J. Biol. Chem., April 12, 2002; 277(16): 14109 - 14115. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. W. Schrum, M. A. Bird, O. Salcher, E.-R. Burchardt, J. W. Grisham, D. A. Brenner, R. A. Rippe, and K. E. Behrns Autocrine expression of activated transforming growth factor-{beta}1 induces apoptosis in normal rat liver Am J Physiol Gastrointest Liver Physiol, January 1, 2001; 280(1): G139 - G148. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Maroun, M. A. Naujokas, M. Holgado-Madruga, A. J. Wong, and M. Park The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase Mol. Cell. Biol., November 15, 2000; 20(22): 8513 - 8525. [Abstract] [Full Text] |
||||
![]() |
H. Kataoka, R. Hamasuna, H. Itoh, N. Kitamura, and M. Koono Activation of Hepatocyte Growth Factor/Scatter Factor in Colorectal Carcinoma Cancer Res., November 1, 2000; 60(21): 6148 - 6159. [Abstract] [Full Text] |
||||
![]() |
C. Seidel, M. Borset, O. Hjertner, D. Cao, N. Abildgaard, H. Hjorth-Hansen, R. D. Sanderson, A. Waage, and A. Sundan High levels of soluble syndecan-1 in myeloma-derived bone marrow: modulation of hepatocyte growth factor activity Blood, November 1, 2000; 96(9): 3139 - 3146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Briggs, I. Grierson, P. Hiscott, and J. A. Hunt Active Scatter Factor (HGF/SF) in Proliferative Vitreoretinal Disease Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3085 - 3094. [Abstract] [Full Text] |
||||
![]() |
M. Beilmann, G. F. Vande Woude, H.-P. Dienes, and P. Schirmacher Hepatocyte growth factor-stimulated invasiveness of monocytes Blood, June 15, 2000; 95(12): 3964 - 3969. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Zhu, Y Hojo, U Ikeda, K Shimada;, and G F BAXTER Production of hepatocyte growth factor during acute myocardial infarction Heart, April 1, 2000; 83(4): 450 - 455. [Abstract] [Full Text] |
||||
![]() |
M. Jo, D. B. Stolz, J. E. Esplen, K. Dorko, G. K. Michalopoulos, and S. C. Strom Cross-talk between Epidermal Growth Factor Receptor and c-Met Signal Pathways in Transformed Cells J. Biol. Chem., March 17, 2000; 275(12): 8806 - 8811. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Maroun, D. K. Moscatello, M. A. Naujokas, M. Holgado-Madruga, A. J. Wong, and M. Park A Conserved Inositol Phospholipid Binding Site within the Pleckstrin Homology Domain of the Gab1 Docking Protein Is Required for Epithelial Morphogenesis J. Biol. Chem., October 29, 1999; 274(44): 31719 - 31726. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Wahl, R.-Y. Hsu, J. L. Huff, M. A. Jelinek, K. Chen, P. Courchesne, S. D. Patterson, J. T. Parsons, and A. A. Welcher Chicken Macrophage Stimulating Protein Is a Ligand of the Receptor Protein-tyrosine Kinase Sea J. Biol. Chem., September 10, 1999; 274(37): 26361 - 26368. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Maroun, M. Holgado-Madruga, I. Royal, M. A. Naujokas, T. M. Fournier, A. J. Wong, and M. Park The Gab1 PH Domain Is Required for Localization of Gab1 at Sites of Cell-Cell Contact and Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase Mol. Cell. Biol., March 1, 1999; 19(3): 1784 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ronen, R. T. Altstock, M. Firon, L. Mittelman, T. Sobe, J. H. Resau, G. F. Vande Woude, and I. Tsarfaty Met-HGF/SF Mediates Growth Arrest and Differentiation in T47D Breast Cancer Cells Cell Growth Differ., February 1, 1999; 10(2): 131 - 140. [Abstract] [Full Text] |
||||
![]() |
J. Deakin and M Lyon Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains J. Cell Sci., January 6, 1999; 112(12): 1999 - 2009. [Abstract] [PDF] |
||||
![]() |
J. M. Siegfried, L. A. Weissfeld, J. D. Luketich, R. J. Weyant, C. T. Gubish, and R. J. Landreneau The clinical significance of hepatocyte growth factor for non-small cell lung cancer Ann. Thorac. Surg., December 1, 1998; 66(6): 1915 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Trusolino, L. Pugliese, and P. M. Comoglio Interactions between scatter factors and their receptors: hints for therapeutic applications FASEB J, October 1, 1998; 12(13): 1267 - 1280. [Abstract] [Full Text] |
||||
![]() |
K. Matsumoto, H. Kataoka, K. Date, and T. Nakamura Cooperative Interaction between alpha - and beta -Chains of Hepatocyte Growth Factor on c-Met Receptor Confers Ligand-induced Receptor Tyrosine Phosphorylation and Multiple Biological Responses J. Biol. Chem., September 4, 1998; 273(36): 22913 - 22920. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Bell, J.-G. Jiang, Q. Chen, Y. Liu, and R. Zarnegar The Upstream Regulatory Regions of the Hepatocyte Growth Factor Gene Promoter Are Essential for Its Expression in Transgenic Mice J. Biol. Chem., March 20, 1998; 273(12): 6900 - 6908. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Donato, M. J. Gómez-Lechón, R. Jover, T. Nakamura, and J. V. Castell Human Hepatocyte Growth Factor Down-regulates the Expression of Cytochrome P450 Isozymes in Human Hepatocytes in Primary Culture J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 760 - 767. [Abstract] [Full Text] |
||||
![]() |
Y. Hirai, A. Lochter, S. Galosy, S. Koshida, S. Niwa, and M. J. Bissell Epimorphin Functions as a Key Morphoregulator for Mammary Epithelial Cells J. Cell Biol., January 12, 1998; 140(1): 159 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Beilmann, M. Odenthal, W. Jung, G. F. Vande Woude, H.-P. Dienes, and P. Schirmacher Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes Blood, December 1, 1997; 90(11): 4450 - 4458. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-X. Liu, Y. Kato, M. Kato, T.-I. Kaku, T. Nakamura, and Y. Sugiyama Existence of two nonlinear elimination mechanisms for hepatocyte growth factor in rats Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E891 - E897. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Fixman, M. Holgado-Madruga, L. Nguyen, D. M. Kamikura, T. M. Fournier, A. J. Wong, and M. Park Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1 J. Biol. Chem., August 8, 1997; 272(32): 20167 - 20172. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Furugori, O. Kurauchi, A. Itakura, Y. Kanou, Y. Murata, S. Mizutani, H. Seo, Y. Tomoda, and T. Nakamura Levels of Hepatocyte Growth Factor and Its Messenger Ribonucleic Acid in Uncomplicated Pregnancies and Those Complicated by Preeclampsia J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2726 - 2730. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakata, S. J. Stahl, W. G. Taylor, J. M. Rosenberg, K. Sakaguchi, P. T. Wingfield, and J. S. Rubin Heparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms. HEPARAN SULFATE GLYCOSAMINOGLYCAN REQUIREMENT FOR Met BINDING AND SIGNALING J. Biol. Chem., April 4, 1997; 272(14): 9457 - 9463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takai, J. Hara, K. Matsumoto, G. Hosoi, Y. Osugi, A. Tawa, S. Okada, and T. Nakamura Hepatocyte Growth Factor Is Constitutively Produced by Human Bone Marrow Stromal Cells and Indirectly Promotes Hematopoiesis Blood, March 1, 1997; 89(5): 1560 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Jiang, A. Bell, Y. Liu, and R. Zarnegar Transcriptional Regulation of the Hepatocyte Growth Factor Gene by the Nuclear Receptors Chicken Ovalbumin Upstream Promoter Transcription Factor and Estrogen Receptor J. Biol. Chem., February 14, 1997; 272(7): 3928 - 3934. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Skouteris and C. H. Schroder The Hepatocyte Growth Factor Receptor Kinase-mediated Phosphorylation of Lipocortin-1 Transduces the Proliferating Signal of the Hepatocyte Growth Factor J. Biol. Chem., November 1, 1996; 271(44): 27266 - 27273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Dunsmore, J. S. Rubin, S. O. Kovacs, M. Chedid, W. C. Parks, and H. G. Welgus Mechanisms of Hepatocyte Growth Factor Stimulation of Keratinocyte Metalloproteinase Production J. Biol. Chem., October 4, 1996; 271(40): 24576 - 24582. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Miyazawa, T. Shimomura, and N. Kitamura Activation of Hepatocyte Growth Factor in the Injured Tissues Is Mediated by Hepatocyte Growth Factor Activator J. Biol. Chem., February 16, 1996; 271(7): 3615 - 3618. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ashikari, H. Habuchi, and K. Kimata Characterization of Heparan Sulfate Oligosaccharides That Bind to Hepatocyte Growth Factor J. Biol. Chem., December 8, 1995; 270(49): 29586 - 29593. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Zioncheck, L. Richardson, J. Liu, L. Chang, K. L. King, G. L. Bennett, Pèt. Fügedi, S. M. Chamow, R. H. Schwall, and R. J. Stack Sulfated Oligosaccharides Promote Hepatocyte Growth Factor Association and Govern Its Mitogenic Activity J. Biol. Chem., July 14, 1995; 270(28): 16871 - 16878. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Naldini, E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction J. Biol. Chem., January 13, 1995; 270(2): 603 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Plaschke-Schlütter, Jür. Behrens, E. Gherardi, and W. Birchmeier Characterization of the Scatter Factor/Hepatocyte Growth Factor Gene Promoter J. Biol. Chem., January 13, 1995; 270(2): 830 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dugina, A. Alexandrova, K Lane, E Bulanova, and J. Vasiliev The role of the microtubular system in the cell response to HGF/SF J. Cell Sci., January 4, 1995; 108(4): 1659 - 1667. [Abstract] [PDF] |
||||
![]() |
A Streit, C. Stern, C Thery, G. Ireland, S Aparicio, M. Sharpe, and E Gherardi A role for HGF/SF in neural induction and its expression in Hensen's node during gastrulation Development, January 3, 1995; 121(3): 813 - 824. [Abstract] [PDF] |
||||
![]() |
A. Chan, J. Rubin, D. Bottaro, D. Hirschfield, M Chedid, and S. Aaronson Identification of a competitive HGF antagonist encoded by an alternative transcript Science, November 29, 1991; 254(5036): 1382 - 1385. [Abstract] [PDF] |
||||
![]() |
S. Aaronson Growth factors and cancer Science, November 22, 1991; 254(5035): 1146 - 1153. [Abstract] [PDF] |
||||
![]() |
D. Bottaro, J. Rubin, D. Faletto, A. Chan, T. Kmiecik, G. Vande Woude, and S. Aaronson Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product Science, February 15, 1991; 251(4995): 802 - 804. [Abstract] [PDF] |
||||
![]() |
Y.-i. Tsukada, K. Miyazawa, and N. Kitamura High Intensity ERK Signal Mediates Hepatocyte Growth Factor-induced Proliferation Inhibition of the Human Hepatocellular Carcinoma Cell Line HepG2 J. Biol. Chem., October 26, 2001; 276(44): 40968 - 40976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |